While SMAD4 mutation abundance in tumor was not significantly prognostic, high SMAD4 mutation abundance in ctDNA was significantly associated with poorer survival (OS, P < 0.001; PFS, P < 0.001). Here, SMAD4 is linked to neoplasm.